PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL
https://doi.org/10.21518/2079-701X-2017-12-33-35
Abstract
Treatment of arterial hypertension (AH) despite the large variety of antihypertensive drugs currently remains one of the most urgent problems in modern cardiology. However, the scheme used in clinical practice does not always correspond to existing recommendations, in particular, of the European Society of Hypertension, ESH, and the European Society of Cardiology, ESC. Thus, patients with 2–3 degree increase blood pressure (BP) and high or very high added risk often do not get the combination therapy that is required for them in this clinical environment. According to the recommendations of the ESH and ESC patients with hypertension of low/medium risk of development of cardiovascular complications (CVC) and death from them a monotherapy can be prescribed if targeted AP values are achieved [1]. Patients with high or very high risk of CCO and/or AG of Degree 2 and 3 immediately must be prescribed a combination of the two drugs. If the target blood pressure values are not attained, either a combination of two drugs at the maximum therapeutic doses, or replacement of the combination of drugs is prescribed or the 3d, 4th and so on antihypertensive drug is added [2, 3]. Combination therapy may also be administered to patients with hypertension with low/medium risk of development of CVC if the target AP are not reached [3, 4].
About the Authors
N. A. MorinaRussian Federation
O. D. Savkova
Russian Federation
E. A. Fedorova
Russian Federation
I. L. Tsarev
Russian Federation
A. B. Frolkova
Russian Federation
A. E. Tsygankova
Russian Federation
A. A. Sokolova
Russian Federation
PhD in medicine
D. A. Napalkov
Russian Federation
PhD in medicine, Prof.
V. V. Fomin
Russian Federation
corresponding member of RAS, MD, Prof.
References
1. 2013 European society of hypertension/ European society of cardiology Guidelines for the management of arterial hypertension.
2. Алгоритмы ведения пациента с артериальной гипертензией. Общероссийская общественная организация содействия профилактике и лечению артериальной гипертензии «Антигипертензивная лига». СПб., 2015: 5-54.
3. Диагностика и лечение артериальной гипертонии. Клинические рекомендации. Кардиологический вестник, 2015, 1(X): 3-30.
4. Карпов Ю.А. Комбинированная антигипертензивная терапия – приоритетное направление в лечении артериальной гипертонии. РМЖ, 2011, 26: 1568-1571.
5. Диагностика и лечение артериальной гипертензии. Российские рекомендации (четвертый пересмотр). Системные гипертензии, 2010, 3: 5-26.
6. Соколов А.В., Садыкова В.З., Решетько О.В. Анализ врачебных назначений антигипертензивной терапии при выписке из стационара больным с метаболическим синдромом. Современная медицина: актуальные вопросы, 2015, 38-39: 113-118.
Review
For citations:
Morina NA, Savkova OD, Fedorova EA, Tsarev IL, Frolkova AB, Tsygankova AE, Sokolova AA, Napalkov DA, Fomin VV. PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL. Meditsinskiy sovet = Medical Council. 2017;(12):33-35. (In Russ.) https://doi.org/10.21518/2079-701X-2017-12-33-35